These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6675426)

  • 1. Studies on amiflamine, a reversible inhibitor of monoamine oxidase type A, selective for serotonergic neurons.
    Ask AL
    Acta Pharm Suec; 1983; 20(6):473. PubMed ID: 6675426
    [No Abstract]   [Full Text] [Related]  

  • 2. Selective inhibition of monoamine oxidase in monoaminergic neurons in the rat brain.
    Ask AL; Fagervall I; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(2):79-87. PubMed ID: 6646243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoamine oxidase-A selective inhibition in human hypothalamus and liver in-vitro by amiflamine and its metabolites.
    Tipton KF; O'Carroll AM; McCrodden JM; Fowler CJ
    J Pharm Pharmacol; 1985 May; 37(5):352-4. PubMed ID: 2862247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of repeated amiflamine administration on serotonergic and noradrenergic neurotransmission: electrophysiological studies in the rat CNS.
    Blier P; de Montigny C; Azzaro AJ
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Nov; 334(3):253-60. PubMed ID: 3808082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Release of 3H-5-hydroxytryptamine by amiflamine and related phenylalkylamines from rat occipital cortex slices.
    Ask AL; Fagervall I; Huang RB; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 1989 Jun; 339(6):684-9. PubMed ID: 2770890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A behavioral and neurochemical study on the mechanism of the anxiolytic effect of monoamine oxidase inhibitors].
    Maki Y
    Hokkaido Igaku Zasshi; 2001 May; 76(3):133-42. PubMed ID: 11481866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoamine oxidase inhibitor activity of selective and non-selective inhibitors: an in vivo dose-response and time-course study.
    Bhattacharya SK; Mukhopadhyay M; Upadhyay SN
    Indian J Exp Biol; 1986 Jul; 24(7):432-4. PubMed ID: 3817879
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effect of pyrazidole and deprenyl on monoamine oxidase in the rat intestine].
    Mashkovskiĭ MD; Gorkin VZ; Asnina VV; Verevkina IV
    Biull Eksp Biol Med; 1981 Mar; 91(3):309-11. PubMed ID: 6788108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effects of substituted phenylethylamines on brain serotonergic mechanisms.
    Chung Hwang E; Van Woert MH
    J Pharmacol Exp Ther; 1980 May; 213(2):254-60. PubMed ID: 6965983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of amiflamine and related compounds on the accumulation of biogenic monoamines in rat brain slices in vitro and ex vivo in relation to their behavioural effects.
    Rényi L; Ross SB
    Acta Pharmacol Toxicol (Copenh); 1985 May; 56(5):416-26. PubMed ID: 4036634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monoamine oxidase inhibitory effects of some 4-aminophenethylamine derivatives.
    Reyes-Parada M; Scorza MC; Silveira R; Dajas F; Costa G; Tipton KF; Cassels BK
    Biochem Pharmacol; 1994 Apr; 47(8):1365-71. PubMed ID: 7514408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine oxidase inhibitors and serotonin uptake inhibitors: differential effects on [3H]serotonin binding sites in rat brain.
    Savage DD; Mendels J; Frazer A
    J Pharmacol Exp Ther; 1980 Feb; 212(2):259-63. PubMed ID: 7351637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuromuscular effects of monoamine oxidase inhibitors.
    Lieberman JA; Kane JM; Reife R
    J Clin Psychopharmacol; 1985 Aug; 5(4):221-8. PubMed ID: 3874888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. E2011 a novel, selective and reversible inhibitor of monoamine oxidase type A.
    Kagaya T; Kajiwara A; Nagato S; Akasaka K; Kubota A
    J Pharmacol Exp Ther; 1996 Jul; 278(1):243-51. PubMed ID: 8764357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interactions between monoaminergic neurons projecting to the cerebral cortex].
    Descarries L; Ferron A; Reader TA; de Montigny C
    Union Med Can; 1985 Dec; 114(12):964-8, 973. PubMed ID: 3938097
    [No Abstract]   [Full Text] [Related]  

  • 16. Aggression in female mice: contrasting effects of amiflamine (FLA 336), a selective and reversible MAO-type A inhibitor.
    Wallian L; Brain PF; Haug M
    Physiol Behav; 1993 Aug; 54(2):411-4. PubMed ID: 8372140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of various antidepressive agents on brain monoamine oxidase activity].
    Gankina EM; Moskvitina TA; Gorkin VZ; Val'dman AV
    Biull Eksp Biol Med; 1982 Nov; 94(11):29-31. PubMed ID: 7150732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New contributions from basic science to understanding the effects of monoamine oxidase inhibiting antidepressants.
    Murphy DL; Garrick NA; Aulakh CS; Cohen RM
    J Clin Psychiatry; 1984 Jul; 45(7 Pt 2):37-43. PubMed ID: 6735994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile.
    Caille D; Bergis OE; Fankhauser C; Gardes A; Adam R; Charieras T; Grosset A; Rovei V; Jarreau FX
    J Pharmacol Exp Ther; 1996 Apr; 277(1):265-77. PubMed ID: 8613929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective monoamine oxidase inhibitors. Compounds derived from phenethylamine and 1-phenoxy-2-aminopropane.
    Kumar Y; Florvall L; Ask AL; Ross SB; Holm AC; Ogren SO
    Acta Pharm Suec; 1983; 20(5):349-64. PubMed ID: 6666598
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.